Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination
2022 · Scientific Reports · 21 citations
https://doi.org/10.1038/s41598-022-20346-w
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
74
Papers
1.8K
Citations
23
h-index
34
i10-index
Alyson Smith is an academic researcher from Pfizer (United States). The author has contributed to research in topics: Influenza Virus Research Studies & Monoclonal and Polyclonal Antibodies Research & Respiratory viral infections research. The author has an h-index of 23, co-authored 63 publications.
ORCID: 0000-0001-8507-6108Click to start Chat